Stocks and Investing
Stocks and Investing
Thu, October 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Justin Kim Downgraded (AUPH) to Hold and Increased Target to $32 on, Oct 28th, 2021
Justin Kim of Oppenheimer, Downgraded "Aurinia Pharmaceuticals Inc." (AUPH) to Hold and Increased Target from $28 to $32 on, Oct 28th, 2021.
Justin has made no other calls on AUPH in the last 4 months.
There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Justin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Justin
- Douglas Miehm of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Tuesday, October 26th, 2021
Contributing Sources